Global Vaccine Particulate Adjuvants Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Vaccine Particulate Adjuvants Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Vaccine Particulate Adjuvants by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Vaccine Particulate Adjuvants by Country/Region, 2017, 2022 & 2028

2.2 Vaccine Particulate Adjuvants Segment by Type

2.2.1 Oral

2.2.2 Subcutaneous

2.2.3 Intranasal

2.2.4 Intramuscular

2.2.5 Intradermal

2.2.6 Others

2.3 Vaccine Particulate Adjuvants Sales by Type

2.3.1 Global Vaccine Particulate Adjuvants Sales Market Share by Type (2017-2022)

2.3.2 Global Vaccine Particulate Adjuvants Revenue and Market Share by Type (2017-2022)

2.3.3 Global Vaccine Particulate Adjuvants Sale Price by Type (2017-2022)

2.4 Vaccine Particulate Adjuvants Segment by Application

2.4.1 Infectious Diseases

2.4.2 Cancer

2.4.3 Others

2.5 Vaccine Particulate Adjuvants Sales by Application

2.5.1 Global Vaccine Particulate Adjuvants Sale Market Share by Application (2017-2022)

2.5.2 Global Vaccine Particulate Adjuvants Revenue and Market Share by Application (2017-2022)

2.5.3 Global Vaccine Particulate Adjuvants Sale Price by Application (2017-2022)

3 Global Vaccine Particulate Adjuvants by Company

3.1 Global Vaccine Particulate Adjuvants Breakdown Data by Company

3.1.1 Global Vaccine Particulate Adjuvants Annual Sales by Company (2020-2022)

3.1.2 Global Vaccine Particulate Adjuvants Sales Market Share by Company (2020-2022)

3.2 Global Vaccine Particulate Adjuvants Annual Revenue by Company (2020-2022)

3.2.1 Global Vaccine Particulate Adjuvants Revenue by Company (2020-2022)

3.2.2 Global Vaccine Particulate Adjuvants Revenue Market Share by Company (2020-2022)

3.3 Global Vaccine Particulate Adjuvants Sale Price by Company

3.4 Key Manufacturers Vaccine Particulate Adjuvants Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Vaccine Particulate Adjuvants Product Location Distribution

3.4.2 Players Vaccine Particulate Adjuvants Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Vaccine Particulate Adjuvants by Geographic Region

4.1 World Historic Vaccine Particulate Adjuvants Market Size by Geographic Region (2017-2022)

4.1.1 Global Vaccine Particulate Adjuvants Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Vaccine Particulate Adjuvants Annual Revenue by Geographic Region

4.2 World Historic Vaccine Particulate Adjuvants Market Size by Country/Region (2017-2022)

4.2.1 Global Vaccine Particulate Adjuvants Annual Sales by Country/Region (2017-2022)

4.2.2 Global Vaccine Particulate Adjuvants Annual Revenue by Country/Region

4.3 Americas Vaccine Particulate Adjuvants Sales Growth

4.4 APAC Vaccine Particulate Adjuvants Sales Growth

4.5 Europe Vaccine Particulate Adjuvants Sales Growth

4.6 Middle East & Africa Vaccine Particulate Adjuvants Sales Growth

5 Americas

5.1 Americas Vaccine Particulate Adjuvants Sales by Country

5.1.1 Americas Vaccine Particulate Adjuvants Sales by Country (2017-2022)

5.1.2 Americas Vaccine Particulate Adjuvants Revenue by Country (2017-2022)

5.2 Americas Vaccine Particulate Adjuvants Sales by Type

5.3 Americas Vaccine Particulate Adjuvants Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Vaccine Particulate Adjuvants Sales by Region

6.1.1 APAC Vaccine Particulate Adjuvants Sales by Region (2017-2022)

6.1.2 APAC Vaccine Particulate Adjuvants Revenue by Region (2017-2022)

6.2 APAC Vaccine Particulate Adjuvants Sales by Type

6.3 APAC Vaccine Particulate Adjuvants Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Vaccine Particulate Adjuvants by Country

7.1.1 Europe Vaccine Particulate Adjuvants Sales by Country (2017-2022)

7.1.2 Europe Vaccine Particulate Adjuvants Revenue by Country (2017-2022)

7.2 Europe Vaccine Particulate Adjuvants Sales by Type

7.3 Europe Vaccine Particulate Adjuvants Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Vaccine Particulate Adjuvants by Country

8.1.1 Middle East & Africa Vaccine Particulate Adjuvants Sales by Country (2017-2022)

8.1.2 Middle East & Africa Vaccine Particulate Adjuvants Revenue by Country (2017-2022)

8.2 Middle East & Africa Vaccine Particulate Adjuvants Sales by Type

8.3 Middle East & Africa Vaccine Particulate Adjuvants Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Vaccine Particulate Adjuvants

10.3 Manufacturing Process Analysis of Vaccine Particulate Adjuvants

10.4 Industry Chain Structure of Vaccine Particulate Adjuvants

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Vaccine Particulate Adjuvants Distributors

11.3 Vaccine Particulate Adjuvants Customer

12 World Forecast Review for Vaccine Particulate Adjuvants by Geographic Region

12.1 Global Vaccine Particulate Adjuvants Market Size Forecast by Region

12.1.1 Global Vaccine Particulate Adjuvants Forecast by Region (2023-2028)

12.1.2 Global Vaccine Particulate Adjuvants Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Vaccine Particulate Adjuvants Forecast by Type

12.7 Global Vaccine Particulate Adjuvants Forecast by Application

13 Key Players Analysis

13.1 Brenntag Biosector (Denmark)

13.1.1 Brenntag Biosector (Denmark) Company Information

13.1.2 Brenntag Biosector (Denmark) Vaccine Particulate Adjuvants Product Offered

13.1.3 Brenntag Biosector (Denmark) Vaccine Particulate Adjuvants Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Brenntag Biosector (Denmark) Main Business Overview

13.1.5 Brenntag Biosector (Denmark) Latest Developments

13.2 CSL Limited (Australia)

13.2.1 CSL Limited (Australia) Company Information

13.2.2 CSL Limited (Australia) Vaccine Particulate Adjuvants Product Offered

13.2.3 CSL Limited (Australia) Vaccine Particulate Adjuvants Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 CSL Limited (Australia) Main Business Overview

13.2.5 CSL Limited (Australia) Latest Developments

13.3 SEPPIC (France)

13.3.1 SEPPIC (France) Company Information

13.3.2 SEPPIC (France) Vaccine Particulate Adjuvants Product Offered

13.3.3 SEPPIC (France) Vaccine Particulate Adjuvants Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 SEPPIC (France) Main Business Overview

13.3.5 SEPPIC (France) Latest Developments

13.4 Agenus, Inc (US)

13.4.1 Agenus, Inc (US) Company Information

13.4.2 Agenus, Inc (US) Vaccine Particulate Adjuvants Product Offered

13.4.3 Agenus, Inc (US) Vaccine Particulate Adjuvants Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Agenus, Inc (US) Main Business Overview

13.4.5 Agenus, Inc (US) Latest Developments

13.5 Novavax, Inc (US)

13.5.1 Novavax, Inc (US) Company Information

13.5.2 Novavax, Inc (US) Vaccine Particulate Adjuvants Product Offered

13.5.3 Novavax, Inc (US) Vaccine Particulate Adjuvants Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Novavax, Inc (US) Main Business Overview

13.5.5 Novavax, Inc (US) Latest Developments

13.6 SPI Pharma, Inc (US)

13.6.1 SPI Pharma, Inc (US) Company Information

13.6.2 SPI Pharma, Inc (US) Vaccine Particulate Adjuvants Product Offered

13.6.3 SPI Pharma, Inc (US) Vaccine Particulate Adjuvants Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 SPI Pharma, Inc (US) Main Business Overview

13.6.5 SPI Pharma, Inc (US) Latest Developments

13.7 Invivogen (US)

13.7.1 Invivogen (US) Company Information

13.7.2 Invivogen (US) Vaccine Particulate Adjuvants Product Offered

13.7.3 Invivogen (US) Vaccine Particulate Adjuvants Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Invivogen (US) Main Business Overview

13.7.5 Invivogen (US) Latest Developments

13.8 Avanti Polar Lipids, Inc (US)

13.8.1 Avanti Polar Lipids, Inc (US) Company Information

13.8.2 Avanti Polar Lipids, Inc (US) Vaccine Particulate Adjuvants Product Offered

13.8.3 Avanti Polar Lipids, Inc (US) Vaccine Particulate Adjuvants Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Avanti Polar Lipids, Inc (US) Main Business Overview

13.8.5 Avanti Polar Lipids, Inc (US) Latest Developments

13.9 MVP Laboratories, Inc (US)

13.9.1 MVP Laboratories, Inc (US) Company Information

13.9.2 MVP Laboratories, Inc (US) Vaccine Particulate Adjuvants Product Offered

13.9.3 MVP Laboratories, Inc (US) Vaccine Particulate Adjuvants Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 MVP Laboratories, Inc (US) Main Business Overview

13.9.5 MVP Laboratories, Inc (US) Latest Developments

13.10 OZ Biosciences (France)

13.10.1 OZ Biosciences (France) Company Information

13.10.2 OZ Biosciences (France) Vaccine Particulate Adjuvants Product Offered

13.10.3 OZ Biosciences (France) Vaccine Particulate Adjuvants Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 OZ Biosciences (France) Main Business Overview

13.10.5 OZ Biosciences (France) Latest Developments

14 Research Findings and Conclusion

Table 1. Vaccine Particulate Adjuvants Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Vaccine Particulate Adjuvants Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Oral

Table 4. Major Players of Subcutaneous

Table 5. Major Players of Intranasal

Table 6. Major Players of Intramuscular

Table 7. Major Players of Intradermal

Table 8. Major Players of Others

Table 9. Global Vaccine Particulate Adjuvants Sales by Type (2017-2022) & (K Pcs)

Table 10. Global Vaccine Particulate Adjuvants Sales Market Share by Type (2017-2022)

Table 11. Global Vaccine Particulate Adjuvants Revenue by Type (2017-2022) & ($ million)

Table 12. Global Vaccine Particulate Adjuvants Revenue Market Share by Type (2017-2022)

Table 13. Global Vaccine Particulate Adjuvants Sale Price by Type (2017-2022) & (USD/Pcs)

Table 14. Global Vaccine Particulate Adjuvants Sales by Application (2017-2022) & (K Pcs)

Table 15. Global Vaccine Particulate Adjuvants Sales Market Share by Application (2017-2022)

Table 16. Global Vaccine Particulate Adjuvants Revenue by Application (2017-2022)

Table 17. Global Vaccine Particulate Adjuvants Revenue Market Share by Application (2017-2022)

Table 18. Global Vaccine Particulate Adjuvants Sale Price by Application (2017-2022) & (USD/Pcs)

Table 19. Global Vaccine Particulate Adjuvants Sales by Company (2020-2022) & (K Pcs)

Table 20. Global Vaccine Particulate Adjuvants Sales Market Share by Company (2020-2022)

Table 21. Global Vaccine Particulate Adjuvants Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Vaccine Particulate Adjuvants Revenue Market Share by Company (2020-2022)

Table 23. Global Vaccine Particulate Adjuvants Sale Price by Company (2020-2022) & (USD/Pcs)

Table 24. Key Manufacturers Vaccine Particulate Adjuvants Producing Area Distribution and Sales Area

Table 25. Players Vaccine Particulate Adjuvants Products Offered

Table 26. Vaccine Particulate Adjuvants Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Vaccine Particulate Adjuvants Sales by Geographic Region (2017-2022) & (K Pcs)

Table 30. Global Vaccine Particulate Adjuvants Sales Market Share Geographic Region (2017-2022)

Table 31. Global Vaccine Particulate Adjuvants Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Vaccine Particulate Adjuvants Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Vaccine Particulate Adjuvants Sales by Country/Region (2017-2022) & (K Pcs)

Table 34. Global Vaccine Particulate Adjuvants Sales Market Share by Country/Region (2017-2022)

Table 35. Global Vaccine Particulate Adjuvants Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Vaccine Particulate Adjuvants Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Vaccine Particulate Adjuvants Sales by Country (2017-2022) & (K Pcs)

Table 38. Americas Vaccine Particulate Adjuvants Sales Market Share by Country (2017-2022)

Table 39. Americas Vaccine Particulate Adjuvants Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Vaccine Particulate Adjuvants Revenue Market Share by Country (2017-2022)

Table 41. Americas Vaccine Particulate Adjuvants Sales by Type (2017-2022) & (K Pcs)

Table 42. Americas Vaccine Particulate Adjuvants Sales Market Share by Type (2017-2022)

Table 43. Americas Vaccine Particulate Adjuvants Sales by Application (2017-2022) & (K Pcs)

Table 44. Americas Vaccine Particulate Adjuvants Sales Market Share by Application (2017-2022)

Table 45. APAC Vaccine Particulate Adjuvants Sales by Region (2017-2022) & (K Pcs)

Table 46. APAC Vaccine Particulate Adjuvants Sales Market Share by Region (2017-2022)

Table 47. APAC Vaccine Particulate Adjuvants Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Vaccine Particulate Adjuvants Revenue Market Share by Region (2017-2022)

Table 49. APAC Vaccine Particulate Adjuvants Sales by Type (2017-2022) & (K Pcs)

Table 50. APAC Vaccine Particulate Adjuvants Sales Market Share by Type (2017-2022)

Table 51. APAC Vaccine Particulate Adjuvants Sales by Application (2017-2022) & (K Pcs)

Table 52. APAC Vaccine Particulate Adjuvants Sales Market Share by Application (2017-2022)

Table 53. Europe Vaccine Particulate Adjuvants Sales by Country (2017-2022) & (K Pcs)

Table 54. Europe Vaccine Particulate Adjuvants Sales Market Share by Country (2017-2022)

Table 55. Europe Vaccine Particulate Adjuvants Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Vaccine Particulate Adjuvants Revenue Market Share by Country (2017-2022)

Table 57. Europe Vaccine Particulate Adjuvants Sales by Type (2017-2022) & (K Pcs)

Table 58. Europe Vaccine Particulate Adjuvants Sales Market Share by Type (2017-2022)

Table 59. Europe Vaccine Particulate Adjuvants Sales by Application (2017-2022) & (K Pcs)

Table 60. Europe Vaccine Particulate Adjuvants Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Vaccine Particulate Adjuvants Sales by Country (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Vaccine Particulate Adjuvants Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Vaccine Particulate Adjuvants Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Vaccine Particulate Adjuvants Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Vaccine Particulate Adjuvants Sales by Type (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Vaccine Particulate Adjuvants Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Vaccine Particulate Adjuvants Sales by Application (2017-2022) & (K Pcs)

Table 68. Middle East & Africa Vaccine Particulate Adjuvants Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Vaccine Particulate Adjuvants

Table 70. Key Market Challenges & Risks of Vaccine Particulate Adjuvants

Table 71. Key Industry Trends of Vaccine Particulate Adjuvants

Table 72. Vaccine Particulate Adjuvants Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Vaccine Particulate Adjuvants Distributors List

Table 75. Vaccine Particulate Adjuvants Customer List

Table 76. Global Vaccine Particulate Adjuvants Sales Forecast by Region (2023-2028) & (K Pcs)

Table 77. Global Vaccine Particulate Adjuvants Sales Market Forecast by Region

Table 78. Global Vaccine Particulate Adjuvants Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Vaccine Particulate Adjuvants Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Vaccine Particulate Adjuvants Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Americas Vaccine Particulate Adjuvants Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Vaccine Particulate Adjuvants Sales Forecast by Region (2023-2028) & (K Pcs)

Table 83. APAC Vaccine Particulate Adjuvants Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Vaccine Particulate Adjuvants Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Europe Vaccine Particulate Adjuvants Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Vaccine Particulate Adjuvants Sales Forecast by Country (2023-2028) & (K Pcs)

Table 87. Middle East & Africa Vaccine Particulate Adjuvants Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Vaccine Particulate Adjuvants Sales Forecast by Type (2023-2028) & (K Pcs)

Table 89. Global Vaccine Particulate Adjuvants Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Vaccine Particulate Adjuvants Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Vaccine Particulate Adjuvants Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Vaccine Particulate Adjuvants Sales Forecast by Application (2023-2028) & (K Pcs)

Table 93. Global Vaccine Particulate Adjuvants Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Vaccine Particulate Adjuvants Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Vaccine Particulate Adjuvants Revenue Market Share Forecast by Application (2023-2028)

Table 96. Brenntag Biosector (Denmark) Basic Information, Vaccine Particulate Adjuvants Manufacturing Base, Sales Area and Its Competitors

Table 97. Brenntag Biosector (Denmark) Vaccine Particulate Adjuvants Product Offered

Table 98. Brenntag Biosector (Denmark) Vaccine Particulate Adjuvants Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 99. Brenntag Biosector (Denmark) Main Business

Table 100. Brenntag Biosector (Denmark) Latest Developments

Table 101. CSL Limited (Australia) Basic Information, Vaccine Particulate Adjuvants Manufacturing Base, Sales Area and Its Competitors

Table 102. CSL Limited (Australia) Vaccine Particulate Adjuvants Product Offered

Table 103. CSL Limited (Australia) Vaccine Particulate Adjuvants Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 104. CSL Limited (Australia) Main Business

Table 105. CSL Limited (Australia) Latest Developments

Table 106. SEPPIC (France) Basic Information, Vaccine Particulate Adjuvants Manufacturing Base, Sales Area and Its Competitors

Table 107. SEPPIC (France) Vaccine Particulate Adjuvants Product Offered

Table 108. SEPPIC (France) Vaccine Particulate Adjuvants Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 109. SEPPIC (France) Main Business

Table 110. SEPPIC (France) Latest Developments

Table 111. Agenus, Inc (US) Basic Information, Vaccine Particulate Adjuvants Manufacturing Base, Sales Area and Its Competitors

Table 112. Agenus, Inc (US) Vaccine Particulate Adjuvants Product Offered

Table 113. Agenus, Inc (US) Vaccine Particulate Adjuvants Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 114. Agenus, Inc (US) Main Business

Table 115. Agenus, Inc (US) Latest Developments

Table 116. Novavax, Inc (US) Basic Information, Vaccine Particulate Adjuvants Manufacturing Base, Sales Area and Its Competitors

Table 117. Novavax, Inc (US) Vaccine Particulate Adjuvants Product Offered

Table 118. Novavax, Inc (US) Vaccine Particulate Adjuvants Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 119. Novavax, Inc (US) Main Business

Table 120. Novavax, Inc (US) Latest Developments

Table 121. SPI Pharma, Inc (US) Basic Information, Vaccine Particulate Adjuvants Manufacturing Base, Sales Area and Its Competitors

Table 122. SPI Pharma, Inc (US) Vaccine Particulate Adjuvants Product Offered

Table 123. SPI Pharma, Inc (US) Vaccine Particulate Adjuvants Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 124. SPI Pharma, Inc (US) Main Business

Table 125. SPI Pharma, Inc (US) Latest Developments

Table 126. Invivogen (US) Basic Information, Vaccine Particulate Adjuvants Manufacturing Base, Sales Area and Its Competitors

Table 127. Invivogen (US) Vaccine Particulate Adjuvants Product Offered

Table 128. Invivogen (US) Vaccine Particulate Adjuvants Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 129. Invivogen (US) Main Business

Table 130. Invivogen (US) Latest Developments

Table 131. Avanti Polar Lipids, Inc (US) Basic Information, Vaccine Particulate Adjuvants Manufacturing Base, Sales Area and Its Competitors

Table 132. Avanti Polar Lipids, Inc (US) Vaccine Particulate Adjuvants Product Offered

Table 133. Avanti Polar Lipids, Inc (US) Vaccine Particulate Adjuvants Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 134. Avanti Polar Lipids, Inc (US) Main Business

Table 135. Avanti Polar Lipids, Inc (US) Latest Developments

Table 136. MVP Laboratories, Inc (US) Basic Information, Vaccine Particulate Adjuvants Manufacturing Base, Sales Area and Its Competitors

Table 137. MVP Laboratories, Inc (US) Vaccine Particulate Adjuvants Product Offered

Table 138. MVP Laboratories, Inc (US) Vaccine Particulate Adjuvants Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 139. MVP Laboratories, Inc (US) Main Business

Table 140. MVP Laboratories, Inc (US) Latest Developments

Table 141. OZ Biosciences (France) Basic Information, Vaccine Particulate Adjuvants Manufacturing Base, Sales Area and Its Competitors

Table 142. OZ Biosciences (France) Vaccine Particulate Adjuvants Product Offered

Table 143. OZ Biosciences (France) Vaccine Particulate Adjuvants Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 144. OZ Biosciences (France) Main Business

Table 145. OZ Biosciences (France) Latest Developments

List of Figures

Figure 1. Picture of Vaccine Particulate Adjuvants

Figure 2. Vaccine Particulate Adjuvants Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Vaccine Particulate Adjuvants Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Vaccine Particulate Adjuvants Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Vaccine Particulate Adjuvants Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Oral

Figure 10. Product Picture of Subcutaneous

Figure 11. Product Picture of Intranasal

Figure 12. Product Picture of Intramuscular

Figure 13. Product Picture of Intradermal

Figure 14. Product Picture of Others

Figure 15. Global Vaccine Particulate Adjuvants Sales Market Share by Type in 2021

Figure 16. Global Vaccine Particulate Adjuvants Revenue Market Share by Type (2017-2022)

Figure 17. Vaccine Particulate Adjuvants Consumed in Infectious Diseases

Figure 18. Global Vaccine Particulate Adjuvants Market: Infectious Diseases (2017-2022) & (K Pcs)

Figure 19. Vaccine Particulate Adjuvants Consumed in Cancer

Figure 20. Global Vaccine Particulate Adjuvants Market: Cancer (2017-2022) & (K Pcs)

Figure 21. Vaccine Particulate Adjuvants Consumed in Others

Figure 22. Global Vaccine Particulate Adjuvants Market: Others (2017-2022) & (K Pcs)

Figure 23. Global Vaccine Particulate Adjuvants Sales Market Share by Application (2017-2022)

Figure 24. Global Vaccine Particulate Adjuvants Revenue Market Share by Application in 2021

Figure 25. Vaccine Particulate Adjuvants Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Vaccine Particulate Adjuvants Revenue Market Share by Company in 2021

Figure 27. Global Vaccine Particulate Adjuvants Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Vaccine Particulate Adjuvants Revenue Market Share by Geographic Region in 2021

Figure 29. Global Vaccine Particulate Adjuvants Sales Market Share by Region (2017-2022)

Figure 30. Global Vaccine Particulate Adjuvants Revenue Market Share by Country/Region in 2021

Figure 31. Americas Vaccine Particulate Adjuvants Sales 2017-2022 (K Pcs)

Figure 32. Americas Vaccine Particulate Adjuvants Revenue 2017-2022 ($ Millions)

Figure 33. APAC Vaccine Particulate Adjuvants Sales 2017-2022 (K Pcs)

Figure 34. APAC Vaccine Particulate Adjuvants Revenue 2017-2022 ($ Millions)

Figure 35. Europe Vaccine Particulate Adjuvants Sales 2017-2022 (K Pcs)

Figure 36. Europe Vaccine Particulate Adjuvants Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Vaccine Particulate Adjuvants Sales 2017-2022 (K Pcs)

Figure 38. Middle East & Africa Vaccine Particulate Adjuvants Revenue 2017-2022 ($ Millions)

Figure 39. Americas Vaccine Particulate Adjuvants Sales Market Share by Country in 2021

Figure 40. Americas Vaccine Particulate Adjuvants Revenue Market Share by Country in 2021

Figure 41. United States Vaccine Particulate Adjuvants Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Vaccine Particulate Adjuvants Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Vaccine Particulate Adjuvants Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Vaccine Particulate Adjuvants Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Vaccine Particulate Adjuvants Sales Market Share by Region in 2021

Figure 46. APAC Vaccine Particulate Adjuvants Revenue Market Share by Regions in 2021

Figure 47. China Vaccine Particulate Adjuvants Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Vaccine Particulate Adjuvants Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Vaccine Particulate Adjuvants Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Vaccine Particulate Adjuvants Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Vaccine Particulate Adjuvants Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Vaccine Particulate Adjuvants Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Vaccine Particulate Adjuvants Sales Market Share by Country in 2021

Figure 54. Europe Vaccine Particulate Adjuvants Revenue Market Share by Country in 2021

Figure 55. Germany Vaccine Particulate Adjuvants Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Vaccine Particulate Adjuvants Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Vaccine Particulate Adjuvants Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Vaccine Particulate Adjuvants Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Vaccine Particulate Adjuvants Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Vaccine Particulate Adjuvants Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Vaccine Particulate Adjuvants Revenue Market Share by Country in 2021

Figure 62. Egypt Vaccine Particulate Adjuvants Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Vaccine Particulate Adjuvants Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Vaccine Particulate Adjuvants Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Vaccine Particulate Adjuvants Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Vaccine Particulate Adjuvants Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Vaccine Particulate Adjuvants in 2021

Figure 68. Manufacturing Process Analysis of Vaccine Particulate Adjuvants

Figure 69. Industry Chain Structure of Vaccine Particulate Adjuvants

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles